13:17
2026-08-05
pub.towardsai.net
artificial-intelligence
Recurrence Risk Prediction in Breast Cancer From Oncotype DX to Advanced Generative Models
Oncotype DX, the most widely used gene expression assay for breast cancer recurrence risk, has been validated in large prospective trials including NSABP-B14, NSABP-B20, TAILORx, and RxPONDER, and its…